ATR three-lens brief
Evidence-based stock research on ATR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 13.6pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- RSI at 28 — technically oversold.
- Underperforming SPY by 13.6pp over 30 days.
- Analyst mean target $170.14 — 38% above current (7 analysts).
- 8-K filing filed 2026-09-01.
ATR closed at $123.05 (+0.77%) as of 2026-09-11. Market cap: $7.82B. P/E (trailing) 22.0. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $170.14 — 38% above current (7 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; rSI at 28 — technically oversold.. Last quarter: Revenue $1.03B, net income $87.57M, free cash flow $265.98M.
Why three lenses on ATR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ATRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ATR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ATR brief"></iframe>